Hilary S Connery
Overview
Explore the profile of Hilary S Connery including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
851
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Medlock M, Rosmarin D, Connery H, Griffin M, Weiss R, Karakula S, et al.
Am J Addict
. 2017 Aug;
26(7):744-750.
PMID: 28836712
Background And Objectives: Religious coping, one of the most widely studied components of spirituality among psychiatric populations, has rarely been addressed in patients with severe substance use disorders (SUD). The...
32.
McHugh R, Votaw V, Fulciniti F, Connery H, Griffin M, Monti P, et al.
J Subst Abuse Treat
. 2017 Jan;
74:48-53.
PMID: 28132700
The majority of adults seeking substance use disorder treatment also smoke. Smoking is associated with greater substance use disorder severity, poorer treatment outcome, and increased mortality among those with substance...
33.
Votaw V, Wittenauer J, Connery H, Weiss R, McHugh R
Addict Behav
. 2016 Aug;
65:218-223.
PMID: 27544695
Aims: The prevalence of heroin use among nonmedical prescription opioid (NMPO) users has increased in recent years. Identifying characteristics associated with heroin use in this population can help inform efforts...
34.
Marcovitz D, McHugh R, Volpe J, Votaw V, Connery H
Am J Addict
. 2016 Jul;
25(6):472-7.
PMID: 27442456
Background And Objectives: Identifying predictors of early drop out from outpatient treatment of opioid use disorder (OUD) with buprenorphine/naloxone (BN) may improve care for subgroups requiring more intensive engagement to...
35.
Miller A, Nelson A, Livchits V, Greenfield S, Yanova G, Yanov S, et al.
PLoS One
. 2016 Feb;
11(2):e0148910.
PMID: 26871943
Russian Federation's (RF) HIV epidemic is the fastest growing of any country. This study explores factors associated with high HIV risk behavior in tuberculosis (TB) patients with alcohol use disorders...
36.
Suzuki J, Ellison T, Connery H, Surber C, Renner J
Acad Psychiatry
. 2015 May;
40(3):498-502.
PMID: 26017618
Objective: Psychiatrists are well suited to provide office-based opioid treatment (OBOT), but the extent to which psychiatry residents are exposed to buprenorphine training and OBOT during residency remains unknown. Methods:...
37.
McDermott K, Griffin M, Connery H, Hilario E, Fiellin D, Fitzmaurice G, et al.
J Clin Psychiatry
. 2015 Jan;
76(2):189-94.
PMID: 25562462
Objective: Initial medication response has been shown to predict treatment outcome across a variety of substance use disorders, but no studies have examined the predictive power of initial response to...
38.
Hilario E, Griffin M, McHugh R, McDermott K, Connery H, Fitzmaurice G, et al.
J Subst Abuse Treat
. 2014 Aug;
48(1):85-90.
PMID: 25115135
Although research has generally supported the validity of substance use self-reports, some patients deny urine-verified substance use. We examined the prevalence and patterns of denying urinalysis-confirmed opioid use in a...
39.
Suzuki J, Connery H, Ellison T, Renner J
Am J Addict
. 2014 Jul;
23(6):618-22.
PMID: 25065457
Objective: To compare the characteristics, attitudes, and current prescribing practices of recently graduating psychiatrists who completed buprenorphine training during residency to those who never completed any training. Methods: A total...
40.
Greenfield S, Sugarman D, Freid C, Bailey G, Crisafulli M, Kaufman J, et al.
Drug Alcohol Depend
. 2014 Jul;
142:245-53.
PMID: 25042759
Background: This Stage II trial builds on a Stage I trial comparing the single-gender Women's Recovery Group (WRG) to mixed-gender Group Drug Counseling (GDC) that demonstrated preliminary support for the...